Here's your Cheat Sheet to earnings...
Dendreon participates in a sector that can have significant impacts on consumers around the world, well into the future. If appropriate pharmaceuticals can be discovered, the company can potentially see amazing profits...
Several healthcare companies have allowed growth opportunities slide between their fingers...
Here's what you need to know in the hot healthcare world...
Friday’s rally was driven by news that more patients are taking the Seattle-based drug manufacturer’s prostate cancer drug...
DNDN is a tricky stock. If you were to relate it to a human condition, you could say that it suffers from manic depression. The highs are tremendous, but you will have to pay for them with extreme lows.
Take a closer look at the new ratings and price targets...
According to documents obtained by Reuters, Dendreon analyzed the data in its key clinical trial for the prostate cancer treatment Provenge differently than their pre-specified goal stipulated...
Difficulties still haunt the drug manufacturer as Provenge sells more slowly than expected...
Five hot stocks to watch...
Take a closer look at the new ratings and price targets...
Take a closer look at the new ratings and price targets...
Analysis on highly active stocks for investors...
Headlines you need to know this morning…
Analysis on highly active stocks for investors...
Take a closer look at the new ratings and price targets...
Your Cheat Sheet to the top healthcare business news ...
Top headlines traders are reading...
Your Cheat Sheet to the top healthcare business news ...
Here's what analysts had to say about these companies today...
Here's everything you need to know now...
Due to speculation and a flight to safety, several biotech names are avoiding the majority of the pullback...
Your Cheat Sheet to the top healthcare business news ...
Analysis on highly active stocks for investors...
Analysis on highly active stocks for investors...
Analysis on highly active stocks for investors...
Your Cheat Sheet to the top healthcare business news ...
Analysis on highly active stocks for investors...
Dendreon (NASDAQ:DNDN) is one of the most popular day trading stocks on the market. Here are 3 new data points giving short sellers ammunition for huge gains: 1) Following the trials of cancer drugs from Johnson & Johnson (NYSE:JNJ) and Medivation (NASDAQ:MDVN) that yielded positive results so far as Roth Capital is concerned, the company [...]
Here's what analysts had to say about these companies today...